Leuconostoc citreum
Cell therapyexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 12, 2021 (NCT05053165)
Timeline
Indications
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06699121 | Phase 2 | Mar 31, 2025 | LISCure Biosciences |
| NCT07017088 | N/A | Aug 13, 2024 | Wonju Christian Hospital |
| NCT05053165 | Phase 1 | Oct 12, 2021 | LISCure Biosciences, Novotech |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| LISCure Biosciences | For profit | 2 | 2 | 2 | 2021 |
| Novotech | For profit | 1 | 0 | 1 | 2021 |
| Wonju Christian Hospital | Academic/Hospital | 1 | 1 | 1 | 2024 |
3 organizations
Page 1 / 1